Navigation Links
NBTY Reports Third Quarter Results
Date:7/27/2009

RONKONKOMA, N.Y., July 27 /PRNewswire-FirstCall/ -- NBTY, Inc. (NYSE: NTY) (www.NBTY.com), a leading global manufacturer and marketer of nutritional supplements, today announced results for the fiscal third quarter and nine months ended June 30, 2009.

For the fiscal third quarter ended June 30, 2009, net sales were $652 million compared to $535 million for the fiscal third quarter ended June 30, 2008, an increase of $117 million or 22%. Included in this total are net sales of $27 million from Julian Graves, which NBTY acquired in September 2008. The Leiner Health Products business, which was acquired in July 2008, has been fully integrated into NBTY operations and accordingly, its sales can no longer be separately identified.

Net income for the fiscal third quarter ended June 30, 2009 was $46 million, or $0.73 per diluted share, which is comparable to the $46 million, or $0.72 per diluted share, for the fiscal third quarter ended June 30, 2008.

Net income for the fiscal third quarter reflects operational efficiencies and improved supply chain management. Included in expenses for the quarter were the following: $10 million for terminated IT projects determined to be ineffective and uneconomical, $4 million in legal expenses associated with Julian Graves Competition Commission issues in the UK, and a $3 million impairment charge to record the current market value of an idle plant. The aggregate after-tax impact of these items was $0.17 per diluted share.

Adjusted EBITDA for the fiscal third quarter of 2009 was a record $109 million, compared to $87 million for the fiscal third quarter of 2008. The Company's balance sheet continues to be

strong and well capitalized. At June 30, 2009, working capital was $614 million, total assets were $1.9 billion, $325 million remains undrawn under the Company's Revolving Credit Facility, and book value per share was $17.24.

OPERATIONS FOR THE FISCAL THIRD QUARTER ENDED JUNE 30, 2009

Overall gross profit margins for the fiscal third quarter of 2009 were 45% compared to 51% for the fiscal third quarter of 2008. This reflects an on-going trend of private label sales constituting a greater portion of the Company's overall sales. Private label sales traditionally have a lower gross profit and, accordingly, overall gross profit margin decreased.

Net sales for the Wholesale/US Nutrition division, which markets various brands including Nature's Bounty, Osteo Bi-Flex, Rexall, Sundown, Ester-C, Solgar, and private label products, increased $113 million, or 40%, to $396 million.

The Nielsen Company tracks industry-wide sales of vitamins, minerals, herbs and other supplements in the food, drug and mass market sectors. For the thirteen week period ended June 27, 2009, Nielsen reported an increase in the entire category of 9.8%. According to Nielsen, for that same period, the Company's Wholesale brands reported a 10.5% increase.

The Wholesale/US Nutrition division utilizes valuable consumer preference sales data generated by the Company's Vitamin World retail stores and Puritan's Pride Direct Response/E-Commerce operations to empower its wholesale customers with this latest data. The Vitamin World stores are used as a laboratory for new ideas and are an effective tool in determining and monitoring consumer preferences. This information, as well as scanned sales data from the Vitamin World stores, is shared on a real time basis with our wholesale customers to give them a competitive advantage.

Net sales for the North American Retail division, comprised of Vitamin World Stores in the United States and LeNaturiste stores in Canada, were $51 million, compared to $50 million, for the prior like quarter. While operating in a difficult retail environment in the US and

Canada, the Division's same store sales increased 1% for the fiscal third quarter of 2009. Vitamin World's modernization of its stores had a favorable impact on its operations in the fiscal third quarter.

During the fiscal third quarter of 2009, the North American Retail division closed 4 stores and added 1 new store. At the end of the fiscal third quarter of 2009, the North American

Retail division operated a total of 528 stores, consisting of 442 Vitamin World stores in the United States and 86 LeNaturiste stores in Canada.

European Retail net sales for the fiscal third quarter ended June 30, 2009 were $151 million compared to $146 million, for the prior like quarter. European Retail net sales for the third fiscal quarter include $27 million from Julian Graves, which NBTY acquired in September 2008. Excluding Julian Graves sales, European Retail net sales increased 8% in local currency (British Pound Sterling), and decreased 14% in US dollars for the third fiscal quarter, compared to the prior like quarter. European Retail division same store sales in local currency increased 6% from the prior like period.

The Julian Graves acquisition was provisionally approved by the UK Competition Commission on July 22, 2009. The final decision by the UK Competition Commission is expected on or before September 3, 2009. During the third fiscal quarter Julian Graves operated at a breakeven despite not being integrated with the Company's European operations.

The European Retail division continues to leverage its premier status, high street locations and brand awareness in a difficult retail environment. The European Retail division consists of 534 Holland & Barrett stores, 350 Julian Graves stores and 31 GNC stores in the UK, 24 Nature's Way stores in Ireland, and 73 DeTuinen stores in the Netherlands, for a total of 1,012 stores in Europe. During the fiscal third quarter of 2009, Holland & Barrett opened 2 franchised stores in South Africa, for a total of 9 franchised stores in South Africa.

Net sales from Direct Response/E-Commerce operations for the fiscal third quarter of 2009 decreased $2 million, or 3% to $53 million from $55 million for the fiscal third quarter of 2008. As this division varies its promotional strategy throughout the fiscal year, its results should be viewed on an annual and not quarterly basis. For the fiscal third quarter of 2009, compared

with the prior like quarter, gross profit percentage for this division increased 6% to 64%; average order size increased $11.57 to $77.37. Puritan's Pride is the leader in the Direct Response and E-Commerce sectors and continues to increase the number of products available via its catalog and web sites.

OPERATIONS FOR THE FISCAL NINE MONTHS ENDED JUNE 30, 2009

For the fiscal nine months ended June 30, 2009, net sales were $1.9 billion compared to $1.6 billion for the fiscal nine months ended June 30, 2008, an increase of $330 million or 21%.

Net income for the fiscal nine months ended June 30, 2009 was $82 million, or $1.31 per diluted share, compared to $136 million, or $2.06 per diluted share, for the fiscal nine months ended June 30, 2008. Net income for the fiscal nine months ended June 30, 2009 reflects the improved operations for the third quarter, decreases in foreign exchange rates, terminated IT project costs and the aforementioned other costs. The aggregate after-tax impact of these items was $0.27 per diluted share. Overall gross profit margins for the fiscal nine months ended June 30, 2009 were 43% compared to 52% for the fiscal nine months ended June 30, 2008.

As a result of the Leiner acquisition, during the first and second fiscal quarters, the Company experienced lower gross margins on the private label business and additional cost pressures as Leiner inventory levels were not adequate to maintain customer fulfillment levels at the time of its acquisition. In order to maintain adequate customer fulfillment levels, NBTY purchased products at higher costs which negatively impacted results.

NBTY Chairman and CEO, Scott Rudolph, said: "NBTY generated a significant increase in sales for the quarter, particularly in our wholesale sector, which continues to benefit from the Leiner acquisition. We are now experiencing operating leverage generating long-term growth, garnering greater market share and enhancing our position as the global leader in the nutritional supplement industry."

ABOUT NBTY

NBTY is a leading global vertically integrated manufacturer, marketer and distributor of a broad line of high-quality, value-priced nutritional supplements in the United States and throughout the world. Under a number of NBTY and third party brands, the Company offers over 25,000 products, including products marketed by the Company's Nature's Bounty(R) (www.NaturesBounty.com), Vitamin World(R) (www.VitaminWorld.com), Puritan's Pride(R) (www.Puritan.com), Holland & Barrett(R) (www.HollandAndBarrett.com), Rexall(R) (www.Rexall.com), Sundown(R) (www.SundownNutrition.com), MET-Rx(R) (www.MetRX.com), Worldwide Sport Nutrition(R) (www.SportNutrition.com), American Health(R) (www.AmericanHealthUS.com), GNC (UK)(R) (www.GNC.co.uk), DeTuinen(R) (www.DeTuinen.nl),

LeNaturiste(TM) (www.LeNaturiste.com), SISU(R) (www.SISU.com), Solgar(R) (www.Solgar.com), Good 'n' Natural(R) (www.goodnnatural.com), Home Health(TM) (www.homehealthus.com), Julian Graves, and Ester-C(R) (www.Ester-C.com) brands. NBTY routinely posts information that may be important to investors on its web site.

This release refers to non-GAAP financial measures, such as Adjusted EBITDA. "Adjusted EBITDA" is defined as net income, excluding the aggregate amount of all non-cash losses reducing net income, plus interest, taxes, depreciation and amortization. This non-GAAP financial measure is not prepared in accordance with generally accepted accounting principles and may be different from non-GAAP financial measures used by other companies. Non-GAAP financial measures should not be considered as a substitute for, or superior to, measures of financial performance prepared in accordance with GAAP. A reconciliation of the non-GAAP measure to the comparable GAAP measure is included in the attached financial tables. Management believes the presentation of Adjusted EBITDA is relevant and useful because Adjusted EBITDA is a measurement industry

analysts utilize when evaluating NBTY's operating performance. Management also believes Adjusted

EBITDA enhances an investor's understanding of NBTY's results of operations because it measures NBTY's operating performance exclusive of interest and non-cash charges for depreciation and amortization. Management also provides this non-GAAP measurement as a way to help investors better understand its core operating performance, enhance comparisons of NBTY's core operating performance from period to period and to allow better comparisons of NBTY's operating performance to that of its competitors.

This release contains certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 with respect to our financial condition, results of operations and business. These forward-looking statements can be identified by the use of terminology such as "subject to," "believe," "expects," "plan," "project," "estimate," "intend," "may," "will," "should," "can," or "anticipates," or the negative thereof, or variations thereon, or comparable terminology, or by discussions of strategy. Although all of these forward looking statements are believed to be reasonable, they are inherently uncertain. Factors which may materially affect such forward-looking statements include: (i) slow or negative growth in the nutritional supplement industry; (ii) interruption of business or negative impact on sales and earnings due to acts of God, acts of war, terrorism, bio-

terrorism, civil unrest or disruption of mail service; (iii) adverse publicity regarding nutritional supplements; (iv) inability to retain customers of companies (or mailing lists) recently acquired; (v) increased competition; (vi) increased costs; (vii) loss or retirement of key members of management; (viii) increases in the cost of borrowings and/or unavailability of additional debt or equity capital; (ix) unavailability of, or inability to consummate, advantageous acquisitions in the future, including those that may be subject to bankruptcy approval or the inability of NBTY to integrate acquisitions into the mainstream of its business; (x) changes in general worldwide economic and political conditions in the markets in which NBTY may compete from time to time; (xi) the inability of NBTY to gain and/or hold market share of its wholesale and/or retail customers anywhere in the world; (xii) unavailability of

electricity in certain geographical areas; (xiii) the inability of NBTY to obtain and/or renew insurance and/or the costs of the same; (xiv) exposure to and expense of defending and resolving product liability and intellectual property claims and other litigation; (xv) the ability of NBTY to successfully implement its business strategy; (xvi) the inability of NBTY to manage its retail, wholesale, manufacturing and other operations efficiently; (xvii) consumer acceptance of NBTY's products; (xviii) the inability of NBTY to renew leases for its retail locations; (xix) the inability of NBTY's retail stores to attain or maintain profitability; (xx) the absence of clinical trials for many of NBTY's products; (xxi) sales and earnings volatility and/or trends for the Company and its market segments; (xxii) the efficacy of NBTY's Internet and on-line sales and marketing strategies; (xxiii) fluctuations in foreign currencies, including the British pound, the Euro and the Canadian dollar; (xxiv) import-export controls on sales to foreign countries; (xxv) the inability of NBTY to secure favorable new sites for, and delays in opening, new retail and manufacturing locations; (xxvi) introduction of and compliance with new federal, state, local or foreign legislation or regulation or adverse determinations by regulators anywhere in the world (including the banning of products) and more particularly Good Manufacturing Practices in the United States, the Food Supplements Directive and Traditional Herbal Medicinal Products Directive in Europe and Section 404 requirements of the Sarbanes-Oxley Act of 2002; (xxvii) the mix of NBTY's products and the profit margins thereon; (xxviii) the availability and pricing of raw materials; (xxix) risk factors discussed in NBTY's filings with the U.S. Securities and Exchange Commission; (xxx) adverse effects on NBTY as a result of increased energy prices and potentially reduced traffic flow to NBTY's retail locations; (xxxi) adverse tax determinations; (xxxii) the loss of a significant customer of the Company; (xxxiii) potential investment losses as a result of liquidity conditions; and (xxxiv) other factors beyond the Company's control.

Readers are cautioned not to place undue reliance on forward-looking statements. NBTY cannot guarantee future results, trends, events, levels of activity, performance or achievements. NBTY does not undertake and specifically declines any obligation to update, republish or revise forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrences of unanticipated events.

Consequently, such forward-looking statements should be regarded solely as NBTY's current plans, estimates and beliefs.

(TABLES FOLLOW)

                                     NBTY, INC.
                    CONDENSED CONSOLIDATED STATEMENTS OF INCOME
                                    (UNAUDITED)

    (In thousands, except per share amounts)

                                                        Three months
                                                       ended June 30,
                                                   2009              2008

    Net sales                                 $ 651,707          $534,519

    Costs and expenses:
       Cost of sales                            359,240           262,455
       Advertising, promotion and catalog        23,570            35,732
       Selling, general and administrative      182,618           166,058
       IT project termination costs              10,127                 -
                                                575,555           464,245

    Income from operations                       76,152            70,274

    Other income (expense):
         Interest                               (8,402)           (3,721)
         Miscellaneous, net                       3,396             2,417
                                                (5,006)           (1,304)

    Income before provision for income taxes     71,146            68,970

    Provision for income taxes                   25,229            23,444

    Net income                                 $ 45,917           $45,526


    Net income per share:
       Basic                                      $0.74             $0.74
       Diluted                                    $0.73             $0.72

    Weighted average common shares outstanding:
       Basic                                     61,796            61,280
       Diluted                                   63,264            62,830


                                         NBTY, INC.
                       CONDENSED CONSOLIDATED STATEMENTS OF INCOME
                                        (UNAUDITED)

    (In thousands, except per share amounts)

                                                        Nine months
                                                       ended June 30,
                                                   2009              2008

    Net sales                                $1,907,813        $1,577,895

    Costs and expenses:
       Cost of sales                          1,091,386           764,069
       Advertising, promotion and catalog        87,889           108,908
       Selling, general and administrative      553,177           500,590
       IT project termination costs              18,774                 -
                                              1,751,226         1,373,567

    Income from operations                      156,587           204,328

    Other income (expense):
         Interest                              (26,780)          (11,239)
         Miscellaneous, net                     (1,959)            11,089
                                               (28,739)             (150)

    Income before provision for income taxes    127,848           204,178

    Provision for income taxes                   45,386            68,604

    Net income                                 $ 82,462          $135,574


    Net income per share:
       Basic                                      $1.34             $2.11
       Diluted                                    $1.31             $2.06

    Weighted average common shares outstanding:
       Basic                                     61,665            64,105
       Diluted                                   63,124            65,826




                                                          NET SALES
                                                         (Unaudited)
                                                     THREE MONTHS ENDED
                                                           JUNE 30,

                                                                    Percentage
    (In thousands)                            2009           2008     Change


    Wholesale / US Nutrition              $396,162       $283,645       40%

    North American Retail                   51,223         50,415        2%

    European Retail                        151,293        145,670        4%

    Direct Response /  E-Commerce           53,029         54,789       -3%

    Total                                 $651,707       $534,519       22%

                                                   GROSS PROFIT
                                                   PERCENTAGES
                                                   (Unaudited)
                                                THREE MONTHS ENDED
                                                     JUNE 30,

                                                                  Increase
                                            2009        2008    - Decrease


    Wholesale / US Nutrition                 33%         41%         -8%

    North American Retail                    67%         66%          1%

    European Retail                          61%         62%         -1%

    Direct Response /  E-Commerce            64%         58%          6%

    Total                                    45%         51%         -6%

                                                        NET SALES
                                                       (Unaudited)
                                                    NINE MONTHS ENDED
                                                         JUNE 30,

                                                                    Percentage
    (In thousands)                              2009        2008      Change


    Wholesale / US Nutrition              $1,152,930    $801,943         44%

    North American Retail                    151,577     158,501         -4%

    European Retail                          441,757     462,337         -4%

    Direct Response /  E-Commerce            161,549     155,114          4%

    Total                                 $1,907,813  $1,577,895         21%

                                                       GROSS PROFIT
                                                       PERCENTAGES
                                                       (Unaudited)
                                                    NINE MONTHS ENDED
                                                         JUNE 30,

                                                                    Increase
                                                2009        2008  - Decrease


    Wholesale / US Nutrition                     29%         42%        -13%

    North American Retail                        67%         62%          5%

    European Retail                              62%         62%          0%

    Direct Response /  E-Commerce                62%         59%          3%

    Total                                        43%         52%         -9%

                                 ADJUSTED EBITDA**
             Reconciliation of GAAP Measures to Non-GAAP Measures
                                   (Unaudited)

    (In thousands)
                                    THREE MONTHS ENDED
                                      JUNE 30, 2009

                           Pretax  Depreciation
                           Income       and               Non-cash  Adjusted
                           (Loss)  amortization  Interest charges   EBITDA**

    Wholesale /
     US Nutrition         $61,905     $3,681        $-       $24   $65,610

    North American Retail  (2,274)       758         -     5,560     4,044

    European Retail        14,070      3,634         -     5,591    23,295

    Direct Response /
     E-Commerce            18,166      1,245         -       790    20,201

    Segment Results        91,867      9,318         -    11,965   113,150

    Corporate /
     Manufacturing        (20,721)     7,486     8,402       832    (4,001)

    Total                 $71,146    $16,804    $8,402   $12,797  $109,149


                                   THREE MONTHS ENDED
                                     JUNE 30, 2008

                           Pretax  Depreciation
                           Income       and                Non-cash  Adjusted
                          (Loss)*  amortization  Interest  charges   EBITDA**

    Wholesale /
     US Nutrition         $49,136     $2,587        $-       $31     $51,754

    North American Retail   1,873        750         -        18       2,641

    European Retail        28,249      3,049         -        49      31,347

    Direct Response /
     E-Commerce             6,044      1,248         -        23       7,315

    Segment Results        85,302      7,634         -       121      93,057

    Corporate /
     Manufacturing        (16,332)     5,749     3,721       537      (6,325)

    Total                 $68,970    $13,383    $3,721      $658     $86,732


    * REFLECTS REVISED ALLOCATIONS OF CORPORATE/MANUFACTURING COSTS
    **   SINCE ADJUSTED EBITDA IS NOT A MEASURE OF PERFORMANCE CALCULATED IN
    ACCORDANCE WITH U.S. GENERALLY ACCEPTED ACCOUNTING PRINCIPLES ("GAAP"),
    IT SHOULD NOT BE CONSIDERED IN ISOLATION OF, OR AS A SUBSTITUTE FOR OR
    SUPERIOR TO, OTHER MEASURES OF FINANCIAL PERFORMANCE PREPARED IN
    ACCORDANCE WITH GAAP, SUCH AS OPERATING INCOME, NET INCOME AND CASH FLOWS
     FROM OPERATING ACTIVITIES.  IN ADDITION, THE COMPANY'S DEFINITION OF
    ADJUSTED EBITDA IS NOT NECESSARILY COMPARABLE TO SIMILARLY TITLED MEASURES
    REPORTED BY OTHER COMPANIES.

                                 ADJUSTED EBITDA**
              Reconciliation of GAAP Measures to Non-GAAP Measures
                                   (Unaudited)

    (In thousands)
                                         NINE MONTHS ENDED
                                           JUNE 30, 2009

                           Pretax  Depreciation
                           Income      and                 Non-cash  Adjusted
                           (Loss)* amortization  Interest  charges   EBITDA**

    Wholesale /
     US Nutrition        $110,968   $10,991        $-       $(3)    $121,956

    North American Retail  (4,160)    2,255         -     5,607        3,702

    European Retail        60,559    10,598         -     5,681       76,838

    Direct Response /
     E-Commerce            38,119     3,777         -     5,413       47,309

    Segment Results       205,486    27,621         -    16,698      249,805

    Corporate /
     Manufacturing        (77,638)   23,983    26,780     1,836      (25,039)

    Total                $127,848   $51,604   $26,780   $18,534     $224,766


         NINE MONTHS ENDED
             JUNE 30, 2008

                           Pretax  Depreciation
                           Income      and                 Non-cash  Adjusted
                           (Loss)* amortization  Interest  charges   EBITDA**

    Wholesale /
     US Nutrition        $128,678    $7,858        $-        $79    $136,615

    North American Retail  (1,733)    2,404         -        384       1,055

    European Retail        97,582     9,081         -         90     106,753

    Direct Response /
     E-Commerce            25,699     3,988         -         43      29,730

    Segment Results       250,226    23,331         -        596     274,153

    Corporate /
     Manufacturing        (46,048)   17,707    11,239       930      (16,172)

    Total                $204,178   $41,038   $11,239    $1,526     $257,981


    *    REFLECTS REVISED ALLOCATIONS OF CORPORATE/MANUFACTURING COSTS
    **   SINCE ADJUSTED EBITDA IS NOT A MEASURE OF PERFORMANCE CALCULATED IN
    ACCORDANCE WITH U.S. GENERALLY ACCEPTED ACCOUNTING PRINCIPLES ("GAAP"), IT
    SHOULD NOT BE CONSIDERED IN ISOLATION OF, OR AS A SUBSTITUTE FOR OR
    SUPERIOR TO, OTHER MEASURES OF FINANCIAL PERFORMANCE PREPARED IN
    ACCORDANCE WITH GAAP, SUCH AS OPERATING INCOME, NET INCOME AND CASH FLOWS
    FROM OPERATING ACTIVITIES.  IN ADDITION, THE COMPANY'S DEFINITION OF
    ADJUSTED EBITDA IS NOT NECESSARILY COMPARABLE TO SIMILARLY TITLED MEASURES
    REPORTED BY OTHER COMPANIES.

                                        NBTY, Inc.
                        Condensed Consolidated Balance Sheets
                                       (Unaudited)

    (In thousands, except per share amounts)

                                                 June 30,       September 30,
                                                   2009              2008

    Current assets:
       Cash and cash equivalents                $69,817           $90,180
       Accounts receivable, net                 131,754           122,878
       Inventories                              634,613           585,239
       Deferred income taxes                     25,353            25,098
       Other current assets                      36,545            75,971

              Total current assets              898,082           899,366

    Property, plant and equipment, net          387,858           419,066
    Goodwill                                    337,988           342,379
    Intangible assets, net                      216,726           230,424
    Other assets                                 35,260            45,123

         Total assets                        $1,875,914        $1,936,358

    Current liabilities:
       Current portion of long-term debt        $31,635           $33,309
       Accounts payable                         106,999           120,620
       Accrued expenses and other current
        liabilities                             145,732           172,035
          Total current liabilities             284,366           325,964

    Long-term debt, net of current portion      453,454           538,402
    Deferred income taxes                        38,737            49,139
    Other liabilities                            32,724            24,657
          Total liabilities                     809,281           938,162

    Commitments and contingencies

    Stockholders' equity:

    Common stock, $0.008 par; authorized
      175,000 shares; issued and outstanding
      61,872 and 61,599 shares at June 30, 2009
      and September 30, 2008, respectively          495               493
       Capital in excess of par                 144,493           140,990
       Retained earnings                        921,530           839,068
       Accumulated other comprehensive income       115            17,645
            Total stockholders' equity        1,066,633           998,196

      Total liabilities and stockholders'
       equity                                $1,875,914        $1,936,358

                                    NBTY, INC.
                CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
                                   (UNAUDITED)
    (In thousands)
                                                         Nine Months
                                                        ended June 30,
                                                   2009              2008
    Cash flows from operating activities:
    Net income                                  $82,462          $135,574
    Adjustments to reconcile net income to
     cash provided by operating activities:
        Impairments and disposals of assets       4,520               441
        Depreciation and amortization            51,604            41,038
        IT project termination costs             16,521                 -
        Foreign currency transaction loss (gain)  5,113            (1,594)
        Stock-based compensation                  2,013             1,176
        Amortization of deferred charges            951               562
        Allowance for doubtful accounts            (366)             (543)
        Inventory reserves                        5,666             5,676
        Deferred income taxes                       888             1,372
        Excess income tax benefit from exercise
         of stock options                           (55)           (4,984)
        Changes in operating assets and
         liabilities, net of acquisitions:
          Accounts receivable                   (11,129)           (3,376)
          Inventories                           (63,228)          (26,438)
          Other assets                            9,162            11,744
          Accounts payable                       (7,061)              675
          Accrued expenses and other liabilities (8,915)              472
            Net cash provided by operating
             activities                          88,146           161,795

    Cash flows from investing activities:
      Purchase of property, plant and equipment (38,584)          (32,031)
      Purchase of available-for-sale investments      -          (364,917)
      Proceeds from sale of available-for-sale
       investments                                    -           463,087
      Cash paid for acquisitions, net of cash
       acquired                                    (264)           (5,072)
      Acquisition working capital escrow              -           (11,500)
      Escrow refund, net of purchase price
       adjustments                               14,460                 -
            Net cash (used in) provided by
             investing activities               (24,388)           49,567

    Cash flows from financing activities:
      Principal payments under long-term debt
       agreements and capital leases            (25,176)             (720)
      Proceeds from borrowings under the
       Revolving Credit Facility                 95,000                 -
      Principal payments under the Revolving
       Credit Facility                         (155,000)                -
      Excess income tax benefit from exercise
       of stock options                              55             4,984
      Proceeds from stock options exercised       1,437             3,852
      Purchase of treasury stock (subsequently
       retired)                                       -          (188,432)

    Net cash used in financing activities       (83,684)         (180,316)

    Effect of exchange rate changes on cash
     and cash equivalents                          (437)           (1,972)

    Net (decrease) increase in cash and cash
     equivalents                                (20,363)           29,074

    Cash and cash equivalents at beginning
     of period                                   90,180            92,902

    Cash and cash equivalents at end of period  $69,817          $121,976


    Contact: Harvey Kamil                   Carl Hymans
    NBTY, Inc.                              G.S. Schwartz & Co.
    President and Chief Financial Officer   212-725-4500
    631-200-2020                            carlh@schwartz.com


'/>"/>
SOURCE NBTY, Inc.
Copyright©2009 PR Newswire.
All rights reserved


Related medicine news :

1. Research Scientist Reports On Time-Tested Solution To Current Medical Crisis
2. Schering-Plough Reports Proposed Settlement in Litigation Involving Planned Merger with Merck
3. NuVasive Reports Second Quarter 2009 Financial Results
4. Oclaro Reports Positive Adjusted EBITDA in First Post-Merger Quarter
5. Hard to Treat Diseases, Inc. (HTDS) Reports on Ribavirin Research as Potential Treatment for MS
6. Zimmer Holdings, Inc. Reports Second Quarter 2009 Financial Results
7. Wyeth Reports Earnings Results for the 2009 Second Quarter and First Half and Raises Full Year 2009 Guidance
8. Digirad Corporation Reports Second Quarter 2009 Financial Results
9. Affymetrix Reports Second Quarter 2009 Results
10. Exponent Reports Second Quarter 2009 Results
11. Endologix Reports 42% Second Quarter 2009 Revenue Growth
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... 24, 2016 , ... Marcy was in a crisis. Her son James, eight, was out of ... verbally and physically. , “When something upset him, he couldn’t control his emotions,” remembers Marcy. ... throw rocks at my other children and say he was going to kill them. ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience with all ... brackets , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is a revolutionary ...
(Date:6/24/2016)... ... , ... People across the U.S. are sharpening their pencils and honing their ... in which patients and their families pay tribute to a genetic counselor by nominating ... of Genetic Counselors (NSGC) Annual Education Conference (AEC) this September. , In April, ...
(Date:6/24/2016)... Las Vegas, Nevada (PRWEB) , ... June 24, ... ... their Las Vegas client, The Grove Investment Group (TGIG), has initiated cultivation and ... The Grove, in Las Vegas and Pahrump, Nevada. , Puradigm is the manufacturer ...
(Date:6/24/2016)... ... 24, 2016 , ... Venture Construction Group (VCG) sponsors Luke’s Wings ... 20th at the Woodmont Country Club at 1201 Rockville Pike, Rockville, Maryland, 20852. ... service members that have been wounded in battle and their families. Venture Construction Group ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... , June 23, 2016 Research ... MEMS Devices Medical Market Analysis 2016 - Forecast to 2022" ... The report contains up to date financial data ... analysis. Assessment of major trends with potential impact on the ... analysis of market segmentation which comprises of sub markets, regional ...
(Date:6/23/2016)... INDIANAPOLIS , June 23, 2016 If ... Leaders Scholarship is any indication, the future is in ... at www.diabetesscholars.org by the Diabetes Scholars Foundation ... the way of academic and community service excellence. ... since 2012, and continues to advocate for people with ...
(Date:6/23/2016)... -- Research and Markets has announced the ... (United States, China, Japan, Brazil, United Kingdom, Germany, France, ... Surgical Procedure Volumes: ... provides surgical procedure volume data in a geographic context. ... analysis of growth drivers and inhibitors, including world population ...
Breaking Medicine Technology: